<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE:  To investigate the natural history of <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) clones in patients with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA) </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: ��Twenty-seven patients with AA and a detectable <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone were monitored for a median of 5.7 years (range 1.5-11.5 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-two patients received high-dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (HiCy) therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The erythrocyte and granulocyte <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone sizes were measured using flow cytometry and analyzed via CellQuest software </plain></SENT>
<SENT sid="4" pm="."><plain>PE-conjugated anti-glycophorin A, anti-CD15, <z:chebi fb="0" ids="37926">FITC</z:chebi>-conjugated anti-CD59, and FLAER staining were used to define <z:chebi fb="0" ids="24410">glycosylphosphatidylinositol</z:chebi>-AP-deficient cells </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: We found a linear relationship between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone size and the development of intravascular <z:mp ids='MP_0010163'>hemolysis</z:mp>, assessed by <z:chebi fb="4" ids="24996">lactate</z:chebi> dehydrogenase (LDH) values (Pearson correlation coefficient = 0.80, P &lt; 0.001 for erythrocyte <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clones; and Pearson correlation coefficient = 0.73, P &lt; 0.0001 for granulocyte <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clones) </plain></SENT>
<SENT sid="6" pm="."><plain>An erythrocyte <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> size of 3-5% and granulocyte <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> size of 23% were the thresholds to predict <z:mp ids='MP_0010163'>hemolysis</z:mp> as measured by an elevated LDH (receiver operating characteristic analyses with AUC = 0.96 for erythrocyte <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone sizes and AUC = 0.88 for granulocyte <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone sizes) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with small (≤15%) initial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone sizes were less likely to develop an elevated LDH (mean ± SD: 236.9 ± 109.9 vs. 423.1 ± 248.8; P = 0.02) </plain></SENT>
<SENT sid="8" pm="."><plain>Over time, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone sizes remained stable in 25.9% of patients; 48.1% experienced a rise in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone size; and 25.9% experienced a decrease </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The risk of developing clinically significant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> after HiCy therapy appears to be low in AA patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clones, especially for those with small initial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clones and for those who respond to HiCy therapy </plain></SENT>
</text></document>